Literature DB >> 22905450

ICSI outcome of patients with severe oligospermia vs. non-obstructive azoospermia.

B Demir1, I I Arikan, G Bozdag, I Esinler, L Karakoc Sokmensuer, S Gunalp.   

Abstract

OBJECTIVE: To compare the results of intracytoplasmic sperm injection (ICSI) and embryo transfer (ET) cycles in men with severe oligoospermia and non-obstructive azoospermia.
MATERIALS AND METHODS: This study included 91 ICSI cycles performed due to male factor infertility. Patients are divided into two groups according to source of spermatozoa. Group 1 consisted of 38 cycles in which sperm was obtained from testicles (cases with non-obstructive azoospermia). In Group 2, 53 consecutive cycles were included in which ejaculated sperm was available for ICSI in spite of severe oligospermia (< 100,000/ml). Fertilization, embryo quality and clinical pregnancy rates were compared between the groups.
RESULTS: Although, the female age and mean number of oocytes retrieved were similar among the two groups, fertilization rate was significantly lower in the non-obstructive azoospermia (34.6%) group compared to group in which patients underwent ICSI with ejaculate spermatozoa (55.3%) (p < 0.05). However, there were no differences regarding mean number of available grade 1 embryos on day 3 and pregnancy rate between the two groups.
CONCLUSION: Testicular sperm from non-obstructive azoospermia patients had significantly lower fertilization rates than the ejaculated spermatozoa from severe oligospermia patients in ICSI cycles. However, it did not bring about improved pregnancy rate.

Entities:  

Mesh:

Year:  2012        PMID: 22905450

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  1 in total

1.  A novel universal multiplex PCR improves detection of AZFc Y-chromosome microdeletions.

Authors:  Hong-Yun Zheng; Yan Li; Fu-Jin Shen; Yong-Qing Tong
Journal:  J Assist Reprod Genet       Date:  2014-03-11       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.